A+ A-


Cannabis use in the French adult population in 2021



Tendances n° 153, OFDT, 4 p.
December 2022

In 2021, the Health Barometer survey conducted by Santé publique France questioned 23 661 adults about their cannabis use. Almost half of them (47.3%) said they had smoked cannabis at least once in their life. While the share of annual users in 2021 (10.6%) has remained stable since 2017, use in the last month, whether regular (3.0%) or daily (1.7%), is down, a decrease mainly driven by the youngest (18-34 years old). Men were more likely than women to report cannabis use, especially as the frequency of use increases. In addition, the 2021 data confirm a heterogeneous geographical distribution in France, where a North-South divide is still emerging, with higher consumption in regions south of the Loire. The overseas territories continue to show lower levels than in mainland France.

Authors : OlivierLe Nézet, Stanislas Spilka (OFDT), Emmanuel Lahaie, Rapahël Andler (Santé publique France)

Download the PDF file (897 Ko)











Drugs in Europe

2023 EMCDDA European Drug Report

The European Drug Report 2023: Trends and Developments presents the EMCDDA’s latest analysis of the drug situation in Europe. Focusing on illicit drug use, related harms and drug supply, the report contains a comprehensive set of national data across these themes and key harm-reduction interventions. This report is based on information provided to the EMCDDA by the EU Member States, the candidate country Türkiye, and Norway, in an annual reporting process.

  Statistical Bulletin 2023

The annual Statistical Bulletin contains the most recent available data on the drug situation in Europe provided by the Member States. These datasets underpin the analysis presented in the European Drug Report. All data may be viewed interactively on screen and downloaded in Excel format.

The European Union and the drug phenomenon

miniFAQDrugsEurope.jpgThe European Union & the drug phenomenon : Frequently asked questions, joint publication between the EMCDDA and the European Commission, october 2010, 12 p.